Larger, more rigorous clinical trials of gadolinium-texaphyrin have just started, and the approach is also being tried for prostate, pancreatic and neck tumours.
More experiments with the stuff in the brightest square (a combination of oxygen with the metals gallium and gadolinium) led to a surprising conclusion.